TECH - Why Is Fertility Treatment-Focused Firm INVO Bioscience Stock Trading Over 100% Higher Today? | Benzinga
INVO Bioscience Inc (NASDAQ: INVO) announced that it is soliciting waivers from holders of the company’s common stock purchase warrants dated August 8, 2023, of the holder’s right to exercise a cash payment option upon consummation of the previously announced proposed merger with NAYA Biosciences Inc.
Receipt of the waivers is a condition to the consummation of the merger.
Last month, the companies agreed to merge in an all-stock deal.
Under the terms of ...